2025-12-31 · ANDA214741
Glatiramer acetate
glatiramer acetate · original submission 1 · status AP.
Open full application timeline →Open selected original record →
FDA application source year
21 selected records whose approved original-submission status date falls in 2025. Dates and status codes are attributed to the retained official dataset observation.
2025-12-31 · ANDA214741
glatiramer acetate · original submission 1 · status AP.
Open full application timeline →2025-12-22 · NDA218316
semaglutide · original submission 1 · status AP.
Open full application timeline →2025-12-12 · ANDA213641
teriparatide · original submission 1 · status AP.
Open full application timeline →2025-12-12 · ANDA216589
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2025-12-11 · NDA219884
trofinetide · original submission 1 · status AP.
Open full application timeline →2025-11-26 · ANDA218929
dalbavancin hydrochloride · original submission 1 · status AP.
Open full application timeline →2025-11-13 · ANDA215826
leuprolide acetate · original submission 1 · status AP.
Open full application timeline →2025-11-10 · ANDA217591
dalbavancin hydrochloride · original submission 1 · status AP.
Open full application timeline →2025-10-23 · ANDA219465
dalbavancin hydrochloride · original submission 1 · status AP.
Open full application timeline →2025-09-26 · ANDA216294
calcitonin salmon · original submission 1 · status AP.
Open full application timeline →2025-09-15 · ANDA218813
glucagon · original submission 1 · status AP.
Open full application timeline →2025-08-27 · ANDA214568
liraglutide · original submission 1 · status AP.
Open full application timeline →2025-07-22 · ANDA214457
glucagon · original submission 1 · status AP.
Open full application timeline →2025-07-22 · ANDA215421
liraglutide · original submission 1 · status AP.
Open full application timeline →2025-07-09 · ANDA219196
calcitonin salmon · original submission 1 · status AP.
Open full application timeline →2025-06-27 · ANDA219454
ganirelix acetate · original submission 1 · status AP.
Open full application timeline →2025-06-09 · ANDA217437
leuprolide acetate · original submission 1 · status AP.
Open full application timeline →2025-06-03 · ANDA218061
cetrorelix acetate · original submission 1 · status AP.
Open full application timeline →2025-05-07 · ANDA208468
glatiramer acetate · original submission 1 · status AP.
Open full application timeline →2025-04-23 · ANDA218855
ganirelix acetate · original submission 1 · status AP.
Open full application timeline →2025-04-02 · ANDA218115
liraglutide · original submission 1 · status AP.
Open full application timeline →